David H. Persing is EVP & Chief Med/Tech Officer at CEPHEID (CPHD). They have made 7 open-market trades across 1 company since 2008, most recently 2016-11-04.
CIK 0001263113
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CPHD | 14,568 | $771K |
Shares reported on the most recent Form 4, priced at the 2016-10-31 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CPHD | SELL | 2015-02-20 | 2015-02-24 | $58.60 | $293K | -9.3% | +1.0% | +1.0% |
| CPHD | SELL · 10b5-1 | 2015-01-12 | 2015-01-14 | $56.90 | $285K | -9.3% | +1.0% | +1.0% |
| CPHD | SELL · 10b5-1 | 2014-11-28 | 2014-12-02 | $55.78 | $837K | -9.3% | +1.0% | +1.0% |
| CPHD | SELL | 2014-11-26 | 2014-12-01 | $54.62 | $4.1M | -9.3% | +1.0% | +1.0% |
| CPHD | SELL · 10b5-1 | 2014-11-13 | 2014-11-17 | $54.68 | $273K | -9.3% | +1.0% | +1.0% |
| CPHD | SELL · 10b5-1 | 2014-10-30 | 2014-10-31 | $53.34 | $1.1M | -9.3% | +1.0% | +1.0% |
| CPHD | SELL · 10b5-1 | 2014-10-27 | 2014-10-28 | $51.51 | $773K | -9.3% | +1.0% | +1.0% |
| CPHD | SELL · 10b5-1 | 2013-11-14 | 2013-11-18 | $42.18 | $211K | -9.3% | +1.0% | +1.0% |
| CPHD | SELL · 10b5-1 | 2013-11-08 | 2013-11-13 | $41.76 | $209K | -9.3% | +1.0% | +1.0% |
| CPHD | SELL · 10b5-1 | 2013-10-30 | 2013-10-30 | $41.35 | $207K | -9.3% | +1.0% | +1.0% |
| CPHD | SELL · 10b5-1 | 2013-10-18 | 2013-10-22 | $40.59 | $812K | -9.3% | +1.0% | +1.0% |
| CPHD | SELL · 10b5-1 | 2013-09-18 | 2013-09-19 | $39.34 | $197K | -9.3% | +1.0% | +1.0% |
| CPHD | SELL · 10b5-1 | 2013-09-16 | 2013-09-18 | $38.95 | $195K | -9.3% | +1.0% | +1.0% |
| CPHD | SELL · 10b5-1 | 2013-09-05 | 2013-09-09 | $37.99 | $760K | -9.3% | +1.0% | +1.0% |
| CPHD | SELL | 2013-08-30 | 2013-09-04 | $36.62 | $188K | -9.3% | +1.0% | +1.0% |
| CPHD | SELL | 2013-02-22 | 2013-02-25 | $36.13 | $542K | -9.3% | +1.0% | +1.0% |
| CPHD | SELL · 10b5-1 | 2012-07-02 | 2012-07-03 | $45.46 | $455K | -9.3% | +1.0% | +1.0% |
| CPHD | SELL · 10b5-1 | 2012-06-27 | 2012-06-28 | $44.79 | $224K | -9.3% | +1.0% | +1.0% |
| CPHD | SELL · 10b5-1 | 2012-02-07 | 2012-02-09 | $43.47 | $2.0M | -9.3% | +1.0% | +1.0% |
| CPHD | SELL · 10b5-1 | 2011-07-01 | 2011-07-05 | $35.15 | $176K | -9.3% | +1.0% | +1.0% |
| CPHD | SELL · 10b5-1 | 2011-06-30 | 2011-06-30 | $34.46 | $345K | -9.3% | +1.0% | +1.0% |
| CPHD | SELL · 10b5-1 | 2011-06-21 | 2011-06-22 | $33.54 | $335K | -9.3% | +1.0% | +1.0% |
| CPHD | SELL · 10b5-1 | 2011-06-17 | 2011-06-21 | $32.85 | $155K | -9.3% | +1.0% | +1.0% |
| CPHD | SELL · 10b5-1 | 2011-06-15 | 2011-06-16 | $32.85 | $9K | -9.3% | +1.0% | +1.0% |
| CPHD | SELL · 10b5-1 | 2011-05-31 | 2011-06-02 | $32.39 | $162K | -9.3% | +1.0% | +1.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.